In support of its mission to advance the knowledge and practice of allergy, asthma and immunology for optimal patient care the AAAAI continually endeavors to create effective and visible platforms for advocacy on issues involving the specialty and its patients.
To accomplish this goal, the AAAAI works with professional representatives on Capitol Hill under the leadership of the Practice & Policy and Research & Training Divisions of the Board of Directors. AAAAI Board members regularly visit Washington, DC, to meet with Senators and Representatives as well as agency officials who play leadership roles with respect to health policy and research.
The AAAAI has focused for a number of years on increased funding for research initiatives to promote best practices in the management of allergies, asthma and immune deficiency disorders. To allow the specialty to have an even stronger voice in Washington, the AAAAI recently expanded its advocacy efforts to also include legislative and coding and billing issues. Click the links below to find out more about projects.
No Surprises Act
CONNECT Act Support for Telehealth
Food Allergy Research Funding Appropriations Advocacy
AAAAI Supports Climate Change Health Protection and Promotion Act
Appropriations Testimony Encourages CoFAR, NIH funding, CDC Work on AMR
Penicillin Allergy Testing in Antibiotic Stewardship
AAAAI Concerns on Allergy Testing Access Act of 2021
Complying With the New Information Blocking Rules
AAAAI Supports the FASTER Act
2020 AAAAI Advocacy Highlights
AAAAI Advocacy Committee
Find out more about the AAAAI’s initiatives in this video from past Advocacy Committee Chair, Mitchell Grayson, MD, FAAAAI.
Advocacy: Tangible Impacts from Coordinated Efforts
Paul V. Williams, MD, FAAAAI, Chair of the AAAAI Advocacy Committee, provides an update and insight into important efforts underway to help support patients and physicians. Caution: Listeners may be motivated to get involved! (November 19, 2020)
Click here to listen to the podcast.